FDA Drug recall D-0198-2017
Midazolam HCl 50 mg/50 mL in 0.9% Sodium Chloride (1 mg/mL), Single-Dose Syringe, Hospital/Office Use Only, Rx Only, Cantrell Drug Co. 7321…
- FDA Drug
- Class II
- terminated
- Published 2016-12-21
On 2016-12-21 the FDA classified a Class II recall of Midazolam HCl 50 mg/50 mL in 0.9% Sodium Chloride (1 mg/mL), Single-Dose Syringe, Hospital/Office Use Only, Rx Only, Cantrell Drug Co. 7321… by Cantrell Drug, citing lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0198-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2016-11-18 |
| Published | 2016-12-21 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Cantrell Drug |
| Distribution | US |
Product
Midazolam HCl 50 mg/50 mL in 0.9% Sodium Chloride (1 mg/mL), Single-Dose Syringe, Hospital/Office Use Only, Rx Only, Cantrell Drug Co. 7321 Cantrell Road Little Rock, AR 72207, NDC 52533-001-04
Reason
Lack of Assurance of Sterility - the firm is recalling select sterile drug products.
Identifiers
| code_info | Lot: 169619 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0198-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.